Revenue
2022
2023
2024
2025
enGene Therapeutics Inc. (ENGN)
Price$1.82Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $94.5M | $38.3M | $16.5M | $15.5M |
| Operating expenses | $123.2M | $62.3M | $26.1M | $19.4M |
| Operating income | −$123.2M | −$62.3M | −$26.1M | −$19.4M |
| EBITDA | −$122.7M | −$62.0M | −$25.9M | −$19.2M |
| Net income | −$117.3M | −$55.1M | −$99.9M | −$24.5M |
| Basic EPSper basic share | $2.29 | $1.46 | $151.22 | $44.30 |
| Diluted EPSper diluted share | $2.29 | $1.46 | $151.22 | $44.30 |
Owners
Reported shareholders
≈10.15%of listed shares
Forbion Growth Management B.V. / Forbion Growth Opportunities Fund I Cooperatief U.A.6.8M shares · Oct 30, 2024
View holders
| Holder | % owned |
|---|---|
Forbion Growth Management B.V. / Forbion Growth Opportunities Fund I Cooperatief U.A. | ≈10.15%6.8M shares |
BML Capital Management, LLC | ≈9.96%6.67M shares |
Siren, L.L.C. | ≈9.34%6.26M shares |
PERCEPTIVE ADVISORS LLC | ≈7.20%4.82M shares |
AMERIPRISE FINANCIAL INC | ≈3.99%2.68M shares |
Nextech Invest Ltd. | ≈3.47%2.32M shares |
ADAR1 Capital Management, LLC | ≈3.14%2.1M shares |
Vestal Point Capital, LP | ≈2.49%1.67M shares |
ACORN CAPITAL ADVISORS, LLC | ≈1.90%1.27M shares |
Peapod Lane Capital LLC | ≈1.65%1.1M shares |
Balyasny Asset Management L.P. | ≈1.50%1.01M shares |
MILLENNIUM MANAGEMENT LLC | ≈1.44%966.63K shares |
RENAISSANCE TECHNOLOGIES LLC | ≈1.24%829.7K shares |
CITADEL ADVISORS LLC | ≈1.07%717.69K shares |
Affinity Asset Advisors, LLC | ≈0.90%600K shares |
UBS Group AG | ≈0.76%509.09K shares |
Eversept Partners, LP | ≈0.70%469.58K shares |
Kynam Capital Management, LP | ≈0.68%457.86K shares |
Seven Fleet Capital Management LP | ≈0.61%411.07K shares |
JANE STREET GROUP, LLC | ≈0.57%382.46K shares |
Percentages use 66.99M shares of this listed class outstanding on Jun 9, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 30, 2024Form 4 | Forbion Growth Management B.V. +1TenPercentOwner | BuyCommon Shares | 561.8K | $8.90 | $5.00M | 3.03M |
| Oct 8, 2024Form 4 | Forbion Growth Opportunities Fund I Cooperatief U.A. +1TenPercentOwner | BuyCommon Shares | 800 | $6.60 | $5.3K | 2.47M |
| Oct 7, 2024Form 4 | Forbion Growth Opportunities Fund I Cooperatief U.A. +1TenPercentOwner | BuyCommon Shares | 11.8K | $6.55 | $77.6K | 2.47M |
| Oct 4, 2024Form 4 | Forbion Growth Opportunities Fund I Cooperatief U.A. +1TenPercentOwner | BuyCommon Shares | 6.0K | $6.54 | $39.2K | 2.46M |
| Oct 3, 2024Form 4 | Forbion Growth Opportunities Fund I Cooperatief U.A. +1TenPercentOwner | BuyCommon Shares | 5.8K | $6.48 | $37.4K | 2.45M |